A new low-cost hepatitis B vaccine has been launched in India in an effort to reduce the number of cases of liver cancer and cirrhosis in the country.

India-based Cipla Ltd introduced the new vaccine in partnership with Serum Institute of India Private Ltd (SII). Cipla will market the vaccine for adults, while SII will market it for both adults and children.

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details